Healthcare -
Biotechnology - NASDAQ - CN
$ 0.8005
0.253 %
$ 44.3 M
Market Cap
-2.83
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Connect Biopharma Holdings Limited
| Revenue | 26 M |
| Cost Of Revenue | 660 K |
| Gross Profit | 25.4 M |
| Operating Expenses | 48.5 M |
| Operating Income | -22.5 M |
| Other Expenses | -6.82 M |
| Net Income | -15.6 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 26.0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0.7 | 1.0 | 1.0 | 0 | 0 | 0 |
| Gross Profit | 25.4 | (1.0) | (1.0) | 0 | 0 | 0 |
| OPERATING INCOME | ||||||
| Operating Expenses | 48.5 | 62.1 | 114.7 | 97.6 | 29.4 | 16.4 |
| Selling, General and Administrative Expenses | 19.2 | 13.5 | 20.4 | 19.2 | 7.3 | 1.4 |
| Research and Development Expenses | 29.3 | 51.9 | 95.3 | 81.3 | 23.1 | 15.4 |
| Operating Income | (22.5) | (62.1) | (117.7) | (99.2) | (30.3) | (16.0) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0 | 21 K | 6.91 K | 6.43 K | 7.69 K |
| Total Other Income | 7.0 | 2.7 | (0.4) | (103.2) | (89.1) | (8.4) |
| Pre-Tax Income | (15.4) | (59.4) | (116.1) | (204.9) | (119.4) | (24.5) |
| NET INCOME | ||||||
| Tax Provision | 0.2 | 0.1 | 0.3 | 0.3 | 0.9 | (0.4) |
| Net Income | (15.6) | (59.5) | (116.4) | (205.2) | (120.3) | (24.0) |
| EPS | 0.28 | 1.08 | 14.5 | 25 | 14.4 | 3.02 |